Female patients undergoing elective thyroidectomy experienced a lower incidence of postoperative nausea and vomiting when anesthetized with remifentanil compared with sufentanil, according to findings from a prospective observational study. Under a clinical protocol that combined standardized triple antiemetic prophylaxis with an ultrasound-guided nerve block, the choice of intraoperative opioid demonstrated a significant association with patient recovery outcomes over the first 48 hours following surgery.
The authors investigated this question by evaluating whether the pharmacokinetic properties of remifentanil versus sufentanil correspond to differences in nausea and vomiting rates.
The study enrolled 400 female patients undergoing elective thyroidectomy procedures who were divided into two groups based on the intraoperative opioid administered during anesthesia: a remifentanil group and a sufentanil group. To standardize baseline emetic control across both study arms, all participants received identical triple antiemetic prophylaxis consisting of dexamethasone, ondansetron, and diphenhydramine.
The primary clinical outcome evaluated was the cumulative incidence of postoperative nausea and vomiting during the 48-hour period following surgery. The overall rate of postoperative nausea and vomiting was 12.2 percent in the remifentanil cohort compared with 33.3 percent in the sufentanil cohort. This difference between the two intraoperative opioid regimens was statistically significant, with a reported two-sided significance level of P < 0.01.
Secondary clinical outcomes assessed both the incidence and the severity of postoperative nausea and vomiting across distinct recovery phases, as well as postoperative pain levels. Patients receiving remifentanil had lower incidences and lower severity of nausea and vomiting during both the short-term window (defined as 5 to 30 minutes following conscious extubation) and the long-term window (ranging from 30 minutes to 48 hours post-extubation), with all comparisons reaching statistical significance (all P < 0.05). Assessments of postoperative pain scores measured at rest and during coughing or swallowing showed no statistically significant differences between the remifentanil and sufentanil groups at fixed postoperative evaluation points (all P > 0.05).
The investigators also examined whether a pre-existing history of motion sickness altered the observed relationship between opioid selection and postoperative emetic symptoms. An interaction test between opioid type and motion sickness history was not statistically significant (odds ratio 0.37, 95% confidence interval 0.13 to 1.11, P = 0.08). In an exploratory stratified analysis, remifentanil remained associated with a lower incidence of nausea and vomiting among patients with a history of motion sickness (odds ratio 0.19, 95% confidence interval 0.08 to 0.41, P < 0.01) as well as among patients without motion sickness history (odds ratio 0.43, 95% confidence interval 0.19 to 0.97, P = 0.04). The clinical study was registered with the Chinese Clinical Trial Registry under identifier ChiCTR2500107369.
Methodological specifications established that all statistical evaluations were conducted as two-sided tests, with significance defined at a threshold of P less than 0.05 across all primary and secondary endpoints.
In their conclusions, the investigators emphasized that the reduced incidence of postoperative nausea and vomiting associated with remifentanil occurred within a specific multi-component anesthetic framework that combined triple antiemetic prophylaxis with an ultrasound-guided bilateral superficial cervical plexus block. Because the research was conducted as a prospective observational study in female patients undergoing elective thyroidectomy, the findings establish an observed clinical association rather than a direct causal relationship.
Subject of Research: Association between intraoperative opioid selection and postoperative nausea and vomiting after thyroid surgery
Article Title: Association of intraoperative opioid type with postoperative nausea and vomiting in female patients undergoing thyroidectomy: a prospective observational study
Article References: Li, S., Liu, Y., Zhao, X., Li, X., Wang, Y., & Liu, H. (2026). Association of intraoperative opioid type with postoperative nausea and vomiting in female patients undergoing thyroidectomy: a prospective observational study. BMC Anesthesiology. https://doi.org/10.1186/s12871-026-04435-1
Image Credits: AI Generated
DOI: 10.1186/s12871-026-04435-1
Keywords: remifentanil, sufentanil, postoperative nausea and vomiting, thyroidectomy, female patients, intraoperative opioids, elective thyroidectomy, triple antiemetic prophylaxis, dexamethasone, ondansetron, diphenhydramine, superficial cervical plexus block, motion sickness history, conscious extubation, postoperative pain scores, prospective observational study
News Source: Ophelia Keating. (November 18, 2026). Remifentanil Linked to Lower Postoperative Nausea and Vomiting After Thyroidectomy. Scienmag.



